A potential antiviral drug for the coronavirus has flopped in its first randomised clinical trial, disappointing scientists and investors who had high hopes for remdesivir, according to draft documents published accidentally by the World Health Organization and seen by the Financial Times.
根據世界衛生組織(WHO)意外發布、英國《金融時報》看到的檔案草稿，一種潛在的抗新型冠狀病毒藥物在首項隨機臨牀試驗中失敗，令曾經對瑞德西韋(remdesivir)寄予厚望的科學家和投資者失望。
您已閱讀10%（386字），剩餘90%（3656字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。